Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
We aimed to compare the effects of two different vasodilating principles, angiotensin II-receptor blockade and calcium channel blockade, on peripheral insulin-mediated glucose uptake in patients with hypertension and other cardiovascular risk factors. Twenty-one hypertensive patients (11 women and 10 men) with mean age 58.6 years (range 46-75 years), body mass index 29.2 +/- 1.0 kg/m(2) and blood pressure 160 +/- 3/96 +/- 2 mm Hg entered a 4-week run-in period with open-label amlodipine 5 mg. Thereafter they were randomized double-blindly to additional treatment with amlodipine 5 mg or losartan 100 mg. After 8 weeks of treatment, all patients underwent clinical examination and laboratory testing, and 17 of them underwent a hyperinsulinaemic isoglycaemic glucose clamp. After a 4-week open-label wash-out phase, the participants crossed over to the opposite treatment regimen and final examinations with hyperinsulinaemic isoglycaemic glucose clamp after another 8 weeks. Blood pressure was lowered to the same level in both treatment periods. The glucose disposal rate was significantly higher after treatment with losartan 100 mg + amlodipine 5 mg compared to amlodipine 10 mg (4.9 +/- 0.4 vs 4.2 +/- 0.5 mg/kg/min, P = 0.039). Thus our data suggest that angiotensin II-receptor blockade with losartan improves glucose metabolism at the cellular level beyond what can be expected by the vasodilatation and blood pressure reduction alone.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Global burden of hypertension: analysis of worldwide data
Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K., & He, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17741-1 · Cited by 8,594
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Julius, S., Kjeldsen, S. E., Weber, M., Brunner, H. R., Ekman, S., Hansson, L., Hua, T., Laragh, J., McInnes, G. T., Mitchell, L., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16451-9 · Cited by 2,558
Self-citationHypertension and Antihypertensive Therapy as Risk Factors for Type 2 Diabetes Mellitus
Gress, T. W., Nieto, F. J., Shahar, E., Wofford, M. R., & Brancati, F. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421301 · Cited by 1,202
Benson, S. C., Pershadsingh, H. A., Ho, C. I., Chittiboyina, A., Desai, P., Pravenec, M., Qi, N., Wang, J., Avery, M. A., & Kurtz, T. W. (2004) · Hypertension · doi:10.1161/01.hyp.0000123072.34629.57 · Cited by 1,073
Assessment of Insulin Sensitivity in Vivo*
Bergman, R. N., Finegood, D. T., & Ader, M. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-1-45 · Cited by 1,066
Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator–Activated Receptor-γ Activity
Schupp, M., Janke, J., Clasen, R., Unger, T., & Kintscher, U. (2004) · Circulation · doi:10.1161/01.cir.0000127955.36250.65 · Cited by 705
Schiffrin, E. L., Park, J. B., Intengan, H. D., & Touyz, R. M. (2000) · Circulation · doi:10.1161/01.cir.101.14.1653 · Cited by 616
Cited by
Torres, D. M., Jones, F. J., Shaw, J. C., Williams, C. D., Ward, J. A., & Harrison, S. A. (2011) · Hepatology · doi:10.1002/hep.24558 · Cited by 183
Primary aldosteronism decreases insulin secretion and increases insulin clearance in humans
Adler, G. K., Murray, G. R., Turcu, A. F., Nian, H., Yu, C., Solorzano, C. C., Manning, R., Peng, D., & Luther, J. M. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.13922 · Cited by 71
“Chronically elevated angiotensin II in the Ren-2 hypertensive rat worsens skeletal muscle insulin sensitivity via reactive oxygen species,(21) and treatment with angiotensin receptor antagonists improves insulin sensitivity and ameliorates the adverse metabolic effects of thiazide treatment.(22,23) Treatment of primar…”
BackgroundKappert, K., Tsuprykov, O., Kaufmann, J., Fritzsche, J., Ott, I., Goebel, M., Bähr, I. N., Häßle, P.-L., Gust, R., Fleck, E., et al. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.132886 · Cited by 50
Yang, Y., Wei, R., Xing, Y., Tang, L., Zheng, X., Wang, Z., Gao, Y., Li, M., & Chen, X. (2013) · Metabolism · doi:10.1016/j.metabol.2013.08.008 · Cited by 38
“[17] Aksnes TA, Reims HM, Guptha S, et al.”
BackgroundMethodInfluentialPerlstein, T. S., Henry, R. R., Mather, K. J., Rickels, M. R., Abate, N. I., Grundy, S. M., Mai, Y., Albu, J., Marks, J. B., Pool, J. L., et al. (2011) · Clinical Science · doi:10.1042/cs20110284 · Cited by 30
Metadata
- Authors
- Aksnes, T. A., Reims, H. M., Guptha, S., Moan, A., Os, I., & Kjeldsen, S. E.
- Affiliations
- Oslo University Hospital (NO)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- MSD (Norway) (NO)
- Corresponding author
- Aksnes, T A
- Venue
- Journal of Human Hypertension
- Published
- 2006-09-21
- Volume
- 20
- Issue
- 11
- Pages
- 860-866
- ISSN
- 0950-9240 (ISSN-L)
- 1476-5527
- OpenAlex
- W2046837981
- Semantic Scholar
- e8cfdef10aaf4ee25c23d102d6be8702187043f8
- Cited by
- 31
- References
- 26
- Citations by year
- 2023: 1 · 2022: 2 · 2020: 1 · 2018: 1 · 2017: 2 · 2016: 1 · 2015: 3 · 2013: 3 · 2012: 2
- FWCI
- 2.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Journal of Human Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- losartan, angiotensin II receptor blockade, amlodipine, calcium channel blockers, insulin sensitivity, insulin-stimulated glucose uptake, glucose disposal rate, hypertension, cardiovascular risk factors, combination antihypertensive therapy
- MeSH terms
- Aged, Antihypertensive Agents, Blood Glucose, Blood Pressure, Calcium Channel Blockers, Cardiovascular Diseases, Double-Blind Method, Female, Heart Rate, Humans, Hypertension, Insulin, Insulin Resistance, Lipids, Male, Middle Aged, Risk Factors, Uric Acid, Vasodilation, Glucose Clamp Technique, Biomarkers, Treatment Outcome, Amlodipine, Cross-Over Studies, Losartan, Angiotensin II Type 1 Receptor Blockers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors. https://app.cochat.ai/papers/10.1038/sj.jhh.1002087
- The paper
- Aksnes, T. A., Reims, H. M., Guptha, S., Moan, A., Os, I., & Kjeldsen, S. E. (2006). Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors. Journal of Human Hypertension. https://doi.org/10.1038/sj.jhh.1002087
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.